Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Dietary Intervention with Oatmeal in Patients with uncontrolled Type 2 Diabetes Mellitus - A Crossover Study.

Delgado G, Kleber ME, Krämer BK, Morcos M, Humpert PM, Wiegand K, Mauldin A, Kusterer K, Enghöfer M, März W, Segiet T, Lammert A.

Exp Clin Endocrinol Diabetes. 2018 Aug 29. doi: 10.1055/a-0677-6068. [Epub ahead of print]

PMID:
30157531
2.

Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.

Panduru NM, Forsblom C, Saraheimo M, Thorn LM, Gordin D, Elonen N, Harjusalo V, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetologia. 2017 Sep;60(9):1782-1790. doi: 10.1007/s00125-017-4328-x. Epub 2017 Jun 10.

PMID:
28601908
3.

Protective Effects of Liraglutide and Linagliptin in C. elegans as a New Model for Glucose-Induced Neurodegeneration.

Wongchai K, Schlotterer A, Lin J, Humpert PM, Klein T, Hammes HP, Morcos M.

Horm Metab Res. 2016 Jan;48(1):70-5. doi: 10.1055/s-0035-1549876. Epub 2015 May 7.

PMID:
25951323
4.

Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.

Panduru NM, Sandholm N, Forsblom C, Saraheimo M, Dahlström EH, Thorn LM, Gordin D, Tolonen N, Wadén J, Harjutsalo V, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2015 Jun;38(6):1130-7. doi: 10.2337/dc14-2330. Epub 2015 Mar 17.

PMID:
25784666
5.

Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.

Panduru NM, Saraheimo M, Forsblom C, Thorn LM, Gordin D, Wadén J, Tolonen N, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2015 May;38(5):883-90. doi: 10.2337/dc14-2276. Epub 2015 Feb 26.

PMID:
25720601
6.

Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study.

Oikonomou D, Kopf S, von Bauer R, Djuric Z, Cebola R, Sander A, Englert S, Vittas S, Hidmark A, Morcos M, Korosoglou G, Nawroth PP, Humpert PM.

Cardiovasc Diabetol. 2014 Oct 11;13:137. doi: 10.1186/s12933-014-0137-4.

7.

Effects of stress reduction on cardiovascular risk factors in type 2 diabetes patients with early kidney disease - results of a randomized controlled trial (HEIDIS).

Kopf S, Oikonomou D, Hartmann M, Feier F, Faude-Lang V, Morcos M, Häring HU, Herzog W, Bierhaus A, Humpert PM, Nawroth PP.

Exp Clin Endocrinol Diabetes. 2014 Jun;122(6):341-9. doi: 10.1055/s-0034-1372583. Epub 2014 May 5.

PMID:
24798861
8.

Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes.

Kopf S, Oikonomou D, von Eynatten M, Kieser M, Zdunek D, Hess G, Morcos M, Forsblom C, Bierhaus A, Groop PH, Nawroth PP, Humpert PM.

Acta Diabetol. 2014;51(3):479-89. doi: 10.1007/s00592-013-0542-2. Epub 2013 Dec 24.

PMID:
24366425
9.

Urinary n-acetyl-beta-d-glucosaminidase excretion: an indicator of neuropathy in type 2 diabetes.

Kopf S, Oikonomou D, Zdunek D, von Eynatten M, Hess G, Nawroth PP, Bierhaus A, Humpert PM.

Exp Clin Endocrinol Diabetes. 2013 Nov;121(10):601-6. doi: 10.1055/s-0033-1355384. Epub 2013 Sep 20.

PMID:
24057510
10.

Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.

Panduru NM, Forsblom C, Saraheimo M, Thorn L, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2013 Jul;36(7):2077-83. doi: 10.2337/dc12-1868. Epub 2013 Feb 1.

11.

Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy.

Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, Eberhardt M, Schnölzer M, Lasitschka F, Neuhuber WL, Kichko TI, Konrade I, Elvert R, Mier W, Pirags V, Lukic IK, Morcos M, Dehmer T, Rabbani N, Thornalley PJ, Edelstein D, Nau C, Forbes J, Humpert PM, Schwaninger M, Ziegler D, Stern DM, Cooper ME, Haberkorn U, Brownlee M, Reeh PW, Nawroth PP.

Nat Med. 2012 Jun;18(6):926-33. doi: 10.1038/nm.2750. Erratum in: Nat Med. 2012 Sep;18(9):1445. Lasischka, Felix [corrected to Lasitschka, Felix].

PMID:
22581285
12.

Sustained effects of a mindfulness-based stress-reduction intervention in type 2 diabetic patients: design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-study).

Hartmann M, Kopf S, Kircher C, Faude-Lang V, Djuric Z, Augstein F, Friederich HC, Kieser M, Bierhaus A, Humpert PM, Herzog W, Nawroth PP.

Diabetes Care. 2012 May;35(5):945-7. doi: 10.2337/dc11-1343. Epub 2012 Feb 14.

13.

Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?

Fleming T, Cuny J, Nawroth G, Djuric Z, Humpert PM, Zeier M, Bierhaus A, Nawroth PP.

Diabetologia. 2012 Apr;55(4):1151-5. doi: 10.1007/s00125-012-2452-1. Epub 2012 Jan 22.

PMID:
22270223
14.

Left ventricular diastolic function in type 2 diabetes mellitus is associated with myocardial triglyceride content but not with impaired myocardial perfusion reserve.

Korosoglou G, Humpert PM, Ahrens J, Oikonomou D, Osman NF, Gitsioudis G, Buss SJ, Steen H, Schnackenburg B, Bierhaus A, Nawroth PP, Katus HA.

J Magn Reson Imaging. 2012 Apr;35(4):804-11. doi: 10.1002/jmri.22879. Epub 2011 Nov 8.

PMID:
22068959
15.

Proximal neuropathic lesions in distal symmetric diabetic polyneuropathy: findings of high-resolution magnetic resonance neurography.

Pham M, Oikonomou D, Bäumer P, Bierhaus A, Heiland S, Humpert PM, Nawroth PP, Bendszus M.

Diabetes Care. 2011 Mar;34(3):721-3. doi: 10.2337/dc10-1491. Epub 2011 Jan 25.

16.

Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review.

Fleming TH, Humpert PM, Nawroth PP, Bierhaus A.

Gerontology. 2011;57(5):435-43. doi: 10.1159/000322087. Epub 2010 Oct 21. Review.

17.

Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque.

Korosoglou G, Lehrke S, Mueller D, Hosch W, Kauczor HU, Humpert PM, Giannitsis E, Katus HA.

Heart. 2011 May;97(10):823-31. doi: 10.1136/hrt.2010.193201. Epub 2010 Sep 30.

PMID:
20884786
18.

Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.

Roos M, Oikonomou D, von Eynatten M, Luppa PB, Heemann U, Lutz J, Baumann M, Nawroth PP, Bierhaus A, Humpert PM.

Cardiovasc Diabetol. 2010 Sep 7;9:48. doi: 10.1186/1475-2840-9-48.

19.

Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment?

Humpert PM.

Diabetologia. 2010 Mar;53(3):403-5. doi: 10.1007/s00125-009-1652-9. Epub 2010 Jan 6. No abstract available.

PMID:
20052454
20.

Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.

von Eynatten M, Baumann M, Heemann U, Zdunek D, Hess G, Nawroth PP, Bierhaus A, Humpert PM.

Eur J Clin Invest. 2010 Feb;40(2):95-102. doi: 10.1111/j.1365-2362.2009.02220.x. Epub 2009 Nov 11.

PMID:
19912308
21.

Alanine-aminotransferase levels predict impaired glucose tolerance in a worksite population.

Oberlinner C, Zober A, Nawroth PP, Humpert PM, Morcos M.

Acta Diabetol. 2010 Jun;47(2):161-5. doi: 10.1007/s00592-009-0148-x. Epub 2009 Oct 24.

PMID:
19855923
22.

Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.

von Eynatten M, Liu D, Hock C, Oikonomou D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann K, Lutz J, Heemann U, Nawroth PP, Bierhaus A, Humpert PM.

Diabetes. 2009 Sep;58(9):2093-9. doi: 10.2337/db09-0204. Epub 2009 Jun 9.

23.

Retinol-binding protein 4 & atherosclerosis: risk factor or innocent bystander?

von Eynatten M, Humpert PM.

Atherosclerosis. 2009 Sep;206(1):38-9. doi: 10.1016/j.atherosclerosis.2009.04.038. Epub 2009 May 6. No abstract available.

PMID:
19486977
24.

Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.

Buss SJ, Humpert PM, Bekeredjian R, Hardt SE, Zugck C, Schellberg D, Bauer A, Filusch A, Kuecherer H, Katus HA, Korosoglou G.

JACC Cardiovasc Imaging. 2009 May;2(5):535-43. doi: 10.1016/j.jcmg.2009.03.003.

25.

AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis.

Humpert PM, Lukic IK, Thorpe SR, Hofer S, Awad EM, Andrassy M, Deemer EK, Kasper M, Schleicher E, Schwaninger M, Weigand MA, Nawroth PP, Bierhaus A.

J Leukoc Biol. 2009 Sep;86(3):589-97. doi: 10.1189/jlb.1008646. Epub 2009 Apr 28.

26.

Strain-encoded cardiac MR during high-dose dobutamine stress testing: comparison to cine imaging and to myocardial tagging.

Korosoglou G, Futterer S, Humpert PM, Riedle N, Lossnitzer D, Hoerig B, Steen H, Giannitsis E, Osman NF, Katus HA.

J Magn Reson Imaging. 2009 May;29(5):1053-61. doi: 10.1002/jmri.21759.

PMID:
19388131
27.

Association of homozygous SDF-1 3'A genotype with proliferative diabetic retinopathy.

Djuric Z, Sharei V, Rudofsky G, Morcos M, Li H, Hammes HP, Nawroth PP, Bierhaus A, Humpert PM, Jonas JB.

Acta Diabetol. 2010 Mar;47(1):79-82. doi: 10.1007/s00592-009-0119-2. Epub 2009 Apr 21.

PMID:
19381432
28.

External electric muscle stimulation improves burning sensations and sleeping disturbances in patients with type 2 diabetes and symptomatic neuropathy.

Humpert PM, Morcos M, Oikonomou D, Schaefer K, Hamann A, Bierhaus A, Schilling T, Nawroth PP.

Pain Med. 2009 Mar;10(2):413-9. doi: 10.1111/j.1526-4637.2008.00557.x. Epub 2009 Jan 16.

PMID:
19207234
29.

The -174G>C IL-6 gene promoter polymorphism and diabetic microvascular complications.

Rudofsky G Jr, Schlotterer A, Reismann P, Engel J, Grafe IA, Tafel J, Morcos M, Humpert PM, Nawroth P, Bierhaus A, Hamann A.

Horm Metab Res. 2009 Apr;41(4):308-13. doi: 10.1055/s-0028-1119373. Epub 2009 Jan 12.

PMID:
19140096
30.

Evaluation of myocardial perfusion and deformation in patients with acute myocardial infarction treated with primary angioplasty and stent placement.

Korosoglou G, Haars A, Humpert PM, Hardt S, Bekeredjian R, Giannitsis E, Kuecherer H, Katus HA.

Coron Artery Dis. 2008 Nov;19(7):497-506. doi: 10.1097/MCA.0b013e328310904e.

PMID:
18923246
31.

Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.

von Eynatten M, Liu D, Bluemm A, Schuster T, Baumann M, Lutz J, Heemann U, Dugi KA, Nawroth PP, Bierhaus A, Humpert PM.

Clin Endocrinol (Oxf). 2009 Jul;71(1):27-32. doi: 10.1111/j.1365-2265.2008.03412.x.

PMID:
18778396
32.

Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.

Morcos M, Schlotterer A, Sayed AA, Kukudov G, Oikomonou D, Ibrahim Y, Pfisterer F, Schneider J, Bozorgmehr F, Rudofsky G Jr, Schwenger V, Kientsch-Engels R, Hamann A, Zeier M, Dugi K, Yard B, Humpert PM, van der Woude F, Nawroth PP, Bierhaus A.

Horm Metab Res. 2008 Nov;40(11):752-9. doi: 10.1055/s-0028-1082039. Epub 2008 Aug 18.

PMID:
18711692
33.

Retinol-binding protein-4 in experimental and clinical metabolic disease.

von Eynatten M, Humpert PM.

Expert Rev Mol Diagn. 2008 May;8(3):289-99. doi: 10.1586/14737159.8.3.289. Review.

PMID:
18598108
34.

High-mobility group box-1 in ischemia-reperfusion injury of the heart.

Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbäurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A.

Circulation. 2008 Jun 24;117(25):3216-26. doi: 10.1161/CIRCULATIONAHA.108.769331.

PMID:
18574060
35.

The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.

Lukic IK, Humpert PM, Nawroth PP, Bierhaus A.

Ann N Y Acad Sci. 2008 Apr;1126:76-80. doi: 10.1196/annals.1433.059.

PMID:
18448798
36.

Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients: a tissue Doppler echocardiographic study: response to Karamitsos et al.

Humpert PM, Oikonomou D, Morcos M, Kuecherer H, Schilling T, Bierhaus A, Nawroth PP, Katus HA, Korosoglou G.

Diabetes Care. 2008 May;31(5):e40; author reply e41. doi: 10.2337/dc07-2431. No abstract available.

PMID:
18445720
37.

Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling.

Humpert PM, Djuric Z, Zeuge U, Oikonomou D, Seregin Y, Laine K, Eckstein V, Nawroth PP, Bierhaus A.

Mol Med. 2008 May-Jun;14(5-6):301-8. doi: 10.2119/2007-00052.Humpert.

38.

Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: a pilot study.

Lammert A, Kratzsch J, Selhorst J, Humpert PM, Bierhaus A, Birck R, Kusterer K, Hammes HP.

Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):132-4. Epub 2007 Dec 20.

PMID:
18095234
39.

The DG10S478 variant in the TCF7L2 gene is not associated with microvascular complications in type 2 diabetes.

Buchbinder S, Rudofsky G Jr, Humpert PM, Schilling T, Zorn M, Bierhaus A, Nawroth PP.

Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):211-4. Epub 2007 Dec 10.

PMID:
18072015
40.

sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes.

Humpert PM, Papadopoulos G, Schaefer K, Djuric Z, Konrade I, Morcos M, Nawroth PP, Bierhaus A.

Horm Metab Res. 2007 Dec;39(12):899-902. Epub 2007 Nov 28.

PMID:
18046662
41.

High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men.

von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, Nawroth PP, Bierhaus A, Dugi KA.

Atherosclerosis. 2008 Jul;199(1):123-8. Epub 2007 Nov 19.

PMID:
18021784
42.

A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.

Rudofsky G Jr, Schlotterer A, Humpert PM, Tafel J, Morcos M, Nawroth PP, Bierhaus A, Hamann A.

Exp Clin Endocrinol Diabetes. 2008 Jan;116(1):14-7. Epub 2007 Oct 9.

PMID:
17926234
43.

Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample.

Oberlinner C, Humpert PM, Nawroth PP, Zober A, Morcos M.

Acta Diabetol. 2008 Mar;45(1):31-5. Epub 2007 Sep 20.

PMID:
17882349
44.

Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.

Rudofsky G Jr, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A.

Horm Metab Res. 2007 Sep;39(9):665-71.

PMID:
17846974
45.

Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease.

von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, Bierhaus A, Dugi KA, Heemann U, Allolio B, Humpert PM.

Diabetologia. 2007 Sep;50(9):1930-1937. doi: 10.1007/s00125-007-0743-8. Epub 2007 Jul 18.

PMID:
17639305
46.
47.

Toll-like receptor polymorphisms and carotid artery intima-media thickness.

Lepper PM, von Eynatten M, Humpert PM, Triantafilou M, Triantafilou K.

Stroke. 2007 Jul;38(7):e50. Epub 2007 May 17. No abstract available.

PMID:
17510447
48.

Levels of three distinct p75 neurotrophin receptor forms found in human plasma are altered in type 2 diabetic patients.

Humpert PM, Kopf S, Djuric Z, Laine K, Korosoglou G, Rudofsky G Jr, Hamann A, Morcos M, von Eynatten M, Nawroth PP, Bierhaus A.

Diabetologia. 2007 Jul;50(7):1517-22. Epub 2007 May 11.

PMID:
17492429
49.

Non-invasive diagnostic imaging techniques as a window into the diabetic heart: a review of experimental and clinical data.

Korosoglou G, Humpert PM.

Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):211-20. Review.

PMID:
17479436
50.

Promoter polymorphisms of UCP1, UCP2, and UCP3 are not associated with diabetic microvascular complications in type 2 diabetes.

Rudofsky G Jr, Schrödter A, Voron'ko OE, Schlotterer A, Humpert PM, Tafel J, Nawroth PP, Bierhaus A, Hamann A.

Horm Metab Res. 2007 Apr;39(4):306-9. No abstract available.

PMID:
17447170

Supplemental Content

Loading ...
Support Center